Base científica:
1 – Braga PC, Dal Sasso M, Culici M, Alfieri M, Nappi G. Antimicrobial activity of bromelain. Fitoterapia. 2006 Jun;77(4):268-70. doi: 10.1016/j.fitote.2006.02.008. PMID: 16644167.
2 – Maurer HR. Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci. 2001 Aug;58(9):1234-45. doi: 10.1007/PL00000936. PMID: 11577981.
3 – Pavan R, Jain S, Shraddha, Kumar A. Properties and therapeutic application of bromelain: a review. Biotechnol Res Int. 2012;2012:976203. doi: 10.1155/2012/976203. Epub 2012 Dec 13. PMID: 23304525.
4 – Secor ER Jr, Carson WF 4th, Singh A, Pensa M, Guernsey LA, Schramm CM, Thrall RS. Oral bromelain attenuates inflammation in an ovalbumin-induced murine model of asthma. Cell Immunol. 2005 Mar-Apr;237(1):68-75. doi: 10.1016/j.cellimm.2005.08.002. PMID: 16219315.
5 – Fitzhugh DJ, Shan S, Dewhirst MW, Hale LP. Bromelain treatment decreases neutrophil migration to sites of inflammation. Clin Immunol. 2008 Jan;128(1):66-74. doi: 10.1016/j.clim.2008.02.015. PMID: 18417404.
6 – Taussig SJ, Batkin S. Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. J Ethnopharmacol. 1988 Aug;22(2):191-203. doi: 10.1016/0378-8741(88)90127-4. PMID: 3064864.